tiprankstipranks
Trending News
More News >
Mabpharm Limited (HK:2181)
:2181
Hong Kong Market

Compare Mabpharm Limited (2181) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mabpharm Limited
HK$0.50
HK$2.23B
-75.00
100.00%
Antengene Corporation Limited
HK$5.27
HK$2.12B
-8.93
329.49%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
HK$5.71
HK$1.28B
-13.25
192.22%
SinoMab Bioscience Ltd.
HK$1.39
HK$1.87B
-9.46
34.65%
Immunotech Biopharm Ltd
HK$2.68
HK$1.60B
-6.01
2.82%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2181
Mabpharm Limited
0.54
0.26
92.86%
HK:6996
Antengene Corporation Limited
3.35
2.61
352.70%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
5.26
3.56
209.41%
HK:3681
SinoMab Bioscience Ltd.
1.36
0.35
34.65%
HK:6978
Immunotech Biopharm Ltd
2.59
0.09
3.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts